Download PDF
Gesundheitswesen 2015; 77(07): 508-511
DOI: 10.1055/s-0035-1547232
Positionspapier
© Georg Thieme Verlag KG Stuttgart · New York

Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. (DGP) zur elektronischen Zigarette (E-Zigarette)[*]

Position Paper of the German Respiratory Society (DGP) on Electronic Cigarettes (E-Cigarettes) in Cooperation with the following Scientific Societies and Organisations: BVKJ, BdP, DGAUM, DGG, DGIM, DGK, DKG, DGSMP, GPP
D. Nowak
1   Arbeits-, Sozial- und Umweltmedizin, Klinikum der Universität München
,
H. Gohlke
2   Deutsche Gesellschaft für Kardiologie und Deutsche Herzstiftung
,
T. Hering
3   Lungenpraxis Tegel, Berlin
,
F.J. F. Herth
4   Pneumologie und Beatmungsmedizin, Thoraxklinik Heidelberg
,
B. Jany
5   Innere Medizin-Pneumologie, Missionsärztliche Klinik Würzburg
,
T. Raupach
6   Klinik für Kardiologie und Pneumologie, Universitätsklinikum Göttingen
,
T. Welte
7   Innere Medizin-Pneumologie, Medizinische Hochschule Hannover
,
R. Loddenkemper
8   Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin, Berlin
› Author Affiliations
Further Information

Publication History

Publication Date:
23 March 2015 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Positionspapier - E-Zigarette - elektronische - Inhalationsprodukte - Gesundheitsgefahren - Tabakentwöhnung - Regulierung

Key words

Position paper - e-cigarette - electronic inhalation products - harmful health effects - smoking cessation - regulation

* Erstveröffentlichung in Pneumologie 2015; 69: 131–134


 

  • Literatur

  • 1 Aktionsbündnis Nichtrauchen. Elektronische Inhalationsprodukte – Regulierung dringend erforderlich!. ABNR Positionen 9/2014. http://www.abnr.de/files/abnr_positionen_9_webfassung.pdf
    PubMedGoogle Scholar
  • 2 Andreas S, Batra A, Behr J et al. Tabakentwöhnung bei COPD. S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 2014; 68: 237-258
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Bhatnagar A, Whitsel LP, Ribisl KM et al American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research. Electronic cigarettes: a policy statement from the American Heart Association. Circulation 2014; 130: 1418-1436
    CrossrefPubMedGoogle Scholar
  • 4 Brandon TH, Goniewicz ML, Hanna NH et al. Electronic Nicotine Delivery Systems: A Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol 2015; pii:JCO.2014.59.4465 [Epub ahead of print]
    PubMedGoogle Scholar
  • 5 Brown J, Beard E, Kotz D et al. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109: 1531-1540
    CrossrefPubMedGoogle Scholar
  • 6 Bullen C, Howe C, Laugesen M et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382: 1629-1637
    CrossrefPubMedGoogle Scholar
  • 7 Caponnetto P, Campagna D, Cibella F et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013; 8: e66317
    CrossrefPubMedGoogle Scholar
  • 8 Deutsches Krebsforschungszentrum, Stabsstelle Krebsprävention. WHO-Kollaborationszentrum für Tabakkontrolle: Stellungnahme zur kontroversen Diskussion um E-Zigaretten. https://www.dkfz.de/de/tabakkontrolle/download/Publikationen/Stellungnahmen/DKFZ_Stellungnahme_E-Zigarette_2014.pdf
    PubMedGoogle Scholar
  • 9 Fairchild AL, Bayer R, Colgrove J. The renormalization of smoking? E-cigarettes and the tobacco “endgame”. N Engl J Med 2014; 370: 293-295
    CrossrefPubMedGoogle Scholar
  • 10 Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation 2014; 129: 1972-1986
    CrossrefPubMedGoogle Scholar
  • 11 Grando SA. Connections of nicotine to cancer. Nat Rev Cancer 2014; 14: 419-429
    CrossrefPubMedGoogle Scholar
  • 12 Kandel ER, Kandel DB. Shattuck Lecture. A molecular basis for nicotine as a gateway drug. N Engl J Med 2014; 371: 932-943
    CrossrefPubMedGoogle Scholar
  • 13 King AC, Smith LJ, McNamara PJ et al. Passive exposure to electronic cigarette (e-cigarette) use increases desire for combustible and e-cigarettes in young adult smokers. Tob Control 2014; pii: tobaccocontrol-2014-051563
    PubMedGoogle Scholar
  • 14 McRobbie H, Bullen C, Hartmann-Boyce J et al. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014; 12: CD010216
    PubMedGoogle Scholar
  • 15 Meo SA, Al Asiri SA. Effects of electronic cigarette smoking on human health. Eur Rev Med Pharmacol Sci 2014; 18: 3315-3319
    PubMedGoogle Scholar
  • 16 Nowak D, Jörres RA, Rüther T. E-cigarettes – prevention, pulmonary health, and addiction. Dtsch Arztebl Int 2014; 111: 349-355 deutsche Version (Die E-Zigarette – präventivmedizinische, pneumologische und suchtmedizinische Aspekte) online http://www.aerzteblatt.de/pdf.asp?id=159692
    PubMedGoogle Scholar
  • 17 Pisinger C, Døssing M. A systematic review of health effects of electronic cigarettes. Prev Med 2014; 69C: 248-260
    PubMedGoogle Scholar
  • 18 Schraufnagel DE, Blasi F, Drummond MB et al. on behalf of the Forum of International Respiratory Societies: Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med 2014; 190: 611-618
    CrossrefPubMedGoogle Scholar
  • 19 Wills TA, Knight R, Williams RJ et al. Risk factors for exclusive E-cigarette use and dual E-cigarette use and tobacco use in adolescents. Pediatrics 2014; pii: peds.2014-0760. [Epub ahead of print]
    PubMedGoogle Scholar
  • 20 Zhu SH, Sun JY, Bonnevie E et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014; (Suppl. 03) iii3-iii9
    PubMedGoogle Scholar